课题基金 / 基金详情

Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia

Elucidation of molecular mechanism of endochondral ossification targeting novel therapeutic strategy for skeletal dysplasia
阐明软骨内骨化的分子机制,针对骨骼发育不良的新治疗策略
批准号:
17590959
负责人:
YASODA Akihiro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

YASODA Akihiro的其他基金

相似基金

相关文献

中文摘要
翻译
利钠肽家族由三种内源性配体ANP、BNP和CNP及其膜上鸟苷酸环化酶受体GC-A和GC-B组成。我们已经表明,CNP-GC-B系统是软骨内骨生长的强刺激剂,并且通过激活CNP-GC-B系统,在软骨中具有活化的FGFR 3的软骨发育不全小鼠模型中,紊乱的软骨内骨生长得到极大改善。CNP/GC-B/cGMP通过抑制FGF信号通路中MAPK通路的激活,恢复了软骨基质合成的下降。本课题进一步研究了软骨中CNP-GC-B系统与FGF系统的胞内信号相互作用。我们首先发现FGF系统同时刺激MAPK和STAT 1通路,而CNP-GC-B系统不干扰STAT 1通路。我们还发现FGF信号刺激了PI 3/PK B通路,而CNP-GC-B系统干扰了该通路,并且在肝素的条件下,PI 3/PK B系统被抑制。另一方面,FGF途径的激活可剂量依赖性地减少CNP-GC-B系统第二信使cGMP的产生。这些结果表明软骨中CNP-GC-B系统和FGF系统的相互调节作用。选择性利钠肽清除受体激动剂C-ANF(4-23)可剂量依赖性地延长培养的胎鼠软骨细胞,因此,我们认为局部利钠肽清除系统是软骨中CNP-GC-B系统的调节者之一。
英文摘要
Natriuretic peptide family consists of three endogenous ligands, ANP, BNP and CNP, and their membranous guanylyl cyclase receptors, GC-A and GC-B. We have shown that CNP-GC-B system is a strong stimulator of endochondral bone growth and that disturbed endochondral bone growth in mice model of achondroplastic with an activated FGFR3 in cartilage is greatly improved by activation of CNP-GC-B system. As for the mechanism, CNP/GC-B/cGMP restores the decreased cartilaginous matrix synthesis by inhibiting activation of MAPK pathway of FGF signaling.In this project, further we investigated the intracellular signaling interaction between CNP-GC-B system and FGF system in cartilage. First we showed that FGF system stimulates both MAPK and STAT1 pathway and that CNP-GC-B system does not interfere to STAT1 pathway. We also showed that FGF signaling stimulates PI3/PKB pathway to which CNP-GC-B system interferes, and that PI3/PKB system is suppressed under the condition with heparin. On the other hand, activation of FGF pathway decreased the production of cGMP, the second messenger of CNP-GC-B system, dose-dependently. These results exhibit the reciprocal regulation of CNP-GC-B system and FGF system in cartilage.Next we investigated local natriuretic peptide clearance system in cartilage by using fetal mice tibial organ culture system. Selective agonist for natriuretic peptide clearance receptor, C-ANF (4-23), elongated cultured fetal tibiae dose-dependently, and accordingly, we concluded that local natriuretic peptide clearance system works as one of the regulator of CNP-GC-B system in cartilage.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Expression of the aderenomedullin gene in adipose tissue.
脂肪组织中腺髓质素基因的表达。
DOI: --
发表时间: 2005
期刊: Regul Pept 132
影响因子: --
作者: [Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, Itoh H, Nakao K]
通讯作者: Nakao K
DOI: 10.1007/s00198-005-1923-3
发表时间: 2006-01-01
期刊: OSTEOPOROSIS INTERNATIONAL
影响因子: 4
作者: [Natsui, K, Tanaka, K, Nakao, K]
通讯作者: Nakao, K
Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription.
抗甲状腺药物抑制甲状腺激素受体介导的转录。
DOI: --
发表时间: 2006
期刊: J Clin Endocrinol Metab. 92・3
影响因子: --
作者: [Moriyama K, Tagami T, Usui T, Naruse M, Nambu T, Hataya Y, Kanamoto N, Li YS, Yasoda A, Arai H, Nakao K]
通讯作者: Nakao K
Complementary antagonistic actions between C-Type natriuretic peptide and MAPK pathway through FGFR-3 in ATDC5 Cells.
ATDC5 细胞中 C 型利尿钠肽和 MAPK 通路通过 FGFR-3 的互补拮抗作用。
DOI: --
发表时间: 2005
期刊: Bone 36
影响因子: --
作者: [Ozasa A, Komatsu Y, Yasoda A, Miura M, Nakatsuru Y, Sakuma Y, Arai H, Itoh N, Nakao N]
通讯作者: Nakao N
Translational research for novel therapeutic strategy for skeletal dysplasias
  • 批准号:
    21591176
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    YASODA Akihiro
  • 依托单位:
Translational Research of the CNP/GC-B system for Skeletal dysplasias
  • 批准号:
    19591075
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    YASODA Akihiro
  • 依托单位:
海外基金